April 7 | 1:00 pm - 5:00 pm (EDT)
Mark A. Blais, PsyD | Harvard Medical School
The purpose of this workshop is to introduce clinicians to the clinical application and utility of the SPECTRA, a recently developed self-report inventory for adults. Inspired by the hierarchical dimensional model of psychopathology and multivariate research, the SPECTRA (Blais & Sinclair, 2018) is a broadband, self-report inventory that measures Psychopathology, Cognitive Complaints, Psychosocial Functioning, and Suicidal Ideation. The SPECTRA's 96-items generate 15 non-overlapping scales (12 clinical scales, 3 supplemental scales) and a validity index. The 12 clinical scales were selected based on their clinical importance and strong empirical association to the primary dimensions of psychopathology; Internalizing, Externalizing, and Reality Impairing and the global psychopathology factor ( p-Factor). The presence of a superordinate psychopathology p-Factor is perhaps the most important insight produced by multivariate psychopathology research. Findings from genetics, neuroscience, and psychiatric epidemiology suggests the p-Factor may be a psychometric representation of overall brain integrity and neurocognitive efficiency. The SPECTRA is the only assessment inventory specifically designed to measure the p-Factor. The SPECTRA's General Psychopathology Index captures the aggregate influence of all psychiatric symptoms and their associated neurobiological processes, providing clinicians important information regarding illness complexity, persistence, cognitive dysfunction, functional impairment and treatment response. This workshop will briefly review the empirical foundation of Quantitative models of psychopathology. The SPECTRA's development process, psychometric properties, and validity data. But the primary focus will be on clinical application and utility of the SPECTRA and its hierarchical approach to interpreting and integrating assessment data. Additional features of the SPECTRA, validity indicators and the supplemental scales, Cognitive Complaints, Psychosocial Functioning and Suicidal Ideation, will also be discussed.
Goals and Objectives:
1. Review the empirical foundation of Quantitative Models of psychopathology.
2. Describe the SPECTRA development and validation process
3. Illustrate the clinical application and utility of the SPECTRA.
4. Demonstrate a comprehensive strategy for interpreting and integrating SPECTRA data.
This is an introductory workshop, open to all skill levels.